gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · SSIIHealthcareSurgical Instruments

SS Innovations International Inc. Common Stock (SSII)

$2.33+0.87%
Close Nov 3, 2026 · split-adjusted
Nov 2, 2026$2.31▼ 70.61% in range
Nov 3, 2025Low $2.25 · High $7.86Nov 2, 2026
What changed · written from our data
As of Nov 3, 2026

SS Innovations International closed at $2.33 on Nov 3, up 0.87%, 71.4% below its 52-week closing high. Volume of 40.5K shares was 0.70× its 20-day average (below normal).

Split-adjusted performance: -15.9% over one month, -40.3% over six months, -71.4% over one year.

In the quarter ended Jun 30, 2026, revenue was $13.94M, up 39.4% from a year earlier, with a net margin of -19.1%.

Short interest was 69.6K shares at the Oct 15 settlement, up 2.7% from the prior report (0.2% of float, 1.2 days to cover).

Market cap$467.1M200.5M shares
Revenue · quarter$13.9M+39.4% YoY
Diluted EPS$-0.01—
P/E · TTM—P/S 8.9×
Net margin-19.1%Gross 50.9%
Dividend yieldNone
52-week range2.25 – 8.15−71.4% from high
Volume40.5K0.70× 20-day avg
Volatility · 60d46.2%Annualised
Short % of float0.2%1.2 days to cover
Net cash-$987.5KCash $13.6M
Next earnings—Not scheduled
Split-adjusted performance
1W −6.8%1M −15.9%3M −39.5%6M −40.3%YTD −59.0%1Y −71.4%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum26
Revenue growth92
Net margin42
Value (low P/E)—
Size58

Industry medians: 6-month return −9.7%, revenue growth +8.9%, net margin −8.2%, P/E 28.1×.

Short interest

Details →
Shares short69.6K+2.7% vs prior
Days to cover1.2Settled Oct 15
% of float0.2%
Short vol. 10d21.1%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SSIISS Innovations International$2.33+0.87%−40.3%+39.4%−19.1%—$467.1M
CERSCerus$2.34−0.85%−9.7%+6.3%−0.9%—$471.6MCompare
RCELAvita Medical$15.33−0.52%+261.6%+17.8%−35.3%—$474.1MCompare
MDXGMiMedx Group$3.25−0.91%−10.7%−45.2%−13.9%—$474.3MCompare
ANGOAngioDynamics$11.73−0.26%+7.0%+6.9%−8.8%—$493.3MCompare
DCTHDelcath Systems$14.40+0.77%+24.9%+20.6%9.2%939.2$499.7MCompare
NPCENeuropace$12.31−0.24%−27.8%+17.1%−27.2%—$422.5MCompare
SGHTSight Sciences$9.42+2.95%+117.6%+19.5%−19.0%—$518.9MCompare
SIShoulder Innovations$19.82+2.59%+53.4%—−59.1%—$412.6MCompare

News about SS Innovations International

All news →
Zacks Initiates Coverage of SSi With Neutral RecommendationZacks Investment Research · Oct 9, 2026Neutral

Quick answers

What does SS Innovations International do?
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries.
What is SSII's market cap?
$467.14M, based on the Nov 3 close of $2.33.
Does SS Innovations International pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SSII is sold short?
69.6K shares, 0.2% of float, as of Oct 15, 2026.
What sector is SSII in?
Healthcare, in the Surgical Instruments industry.

About SS Innovations International

SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

HQ: Gurugram, 483 employeesListed Jul 9, 2018ssinnovations.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology